spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Healthcare News Roundup: Biopharmaceutical

 HSMN NewsFeed - 10 May 2013
Curis Announces Approval of Erivedge(R) in Australia
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 10 May 2013
Novartis drug Ilaris(R) approved by FDA to treat active systemic juvenile idiopathic arthritis, a serious form of childhood arthritis
Biopharmaceuticals. FDA
 HSMN NewsFeed - 9 May 2013
Warner Chilcott Announces FDA Approval of New Oral Contraceptive
Biopharmaceuticals FDA
 HSMN NewsFeed - 9 May 2013
Cornerstone Therapeutics Acquires Exclusive U.S. Marketing Rights to PERTZYE(R) (pancrelipase) for Treatment of Exocrine Pancreatic Insufficiency in Patients With Cystic Fibrosis
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 8 May 2013
Teva and Alexza Announce Teva’s License to Market ADASUVE(R) in the U.S.
Biopharmaceuticals Licensing
 HSMN NewsFeed - 7 May 2013
Coronado Biosciences Appoints Thomas F. Schaible, Ph.D. as Project Leader, Inflammatory Bowel Disease
Biopharmaceuticals Gastroenterology Personnel
 HSMN NewsFeed - 7 May 2013
Baxter Announces Topline Results of Phase III Study of Immunoglobulin for Alzheimer's Disease
Biopharmaceuticals Neurology
 HSMN NewsFeed - 6 May 2013
Arrowhead Closes $36 Million Private Offering
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 6 May 2013
NeuroPhage, Inc. Raises $6.4 Million In Additional Financing
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 3 May 2013
Bristol-Myers Squibb Receives US FDA sNDA Approval for Use of SUSTIVA(R) (efavirenz) in HIV-1 Infected Pediatric Patients
Biopharmaceuticals HIV/AIDS FDA
 HSMN NewsFeed - 3 May 2013
Ambrx Initiates Collaboration with Bristol-Myers Squibb for Discovery, Development of Next-Generation Antibody Drug Conjugates
Biopharmaceuticals
 HSMN NewsFeed - 2 May 2013
Hyperion Therapeutics Exercises Option to Acquire Rights to BUPHENYL(R) and AMMONUL(R)
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 2 May 2013
A.P. Pharma Appoints New Management Team
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 1 May 2013
Ultragenyx Appoints Eric Yuen, MD as Chief Medical Officer and Senior Vice President
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 May 2013
Actavis Acquires Worldwide Rights for Valeant's Metronidazole 1.3% Vaginal Gel
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 1 May 2013
William L. Ashton Joins Galena Biopharma's Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 1 May 2013
New Guidelines From American Association of Clinical Endocrinologists Recommend Medical Treatment of Obesity
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 30 Apr 2013
Dynavax Names Eddie Gray as Chief Executive Officer and Member of the Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Apr 2013
Henri A. Termeer Joins Moderna Therapeutics Board Of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Apr 2013
ECR Pharmaceuticals Announces Re-launch of Zolpimist(R) and DexPak(R), Divestiture of Hylase(R) and Orbivan(R) Brands, and Dr. Cameron Durrant Named President and CEO
Biopharmaceuticals Personnel Product Launch
 HSMN NewsFeed - 29 Apr 2013
Dave Lemus Promoted to Chief Executive Officer of Sigma-Tau Pharmaceuticals, Inc.
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Apr 2013
Teva Expands Management Team with Appointment of Paul J. Sekhri as Group Executive Vice President, Global Business Development and Chief Strategy Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Apr 2013
Merck & Co., Inc. and Pfizer Enter Worldwide Collaboration Agreement to Develop and Commercialize Ertugliflozin, an Investigational Medicine for Type 2 Diabetes
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 29 Apr 2013
UPLYSO(TM) (alfataliglicerase) Approved in Mexico and Chile for the Treatment of Gaucher Disease
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 29 Apr 2013
BioDelivery Sciences Appoints Thomas W. D'Alonzo to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Apr 2013
Bayer to acquire Conceptus, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 26 Apr 2013
Curis Announces Erivedge(R) Receives Positive CHMP Opinion for Conditional Approval in European Union
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 25 Apr 2013
Retrophin Names Horacio Plotkin, M.D. as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Apr 2013
Alexion Broadens and Strengthens its Executive Leadership Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Apr 2013
Coronado Biosciences Announces Departure of Dr. Bobby W. Sandage, Jr.
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Apr 2013
Launch of the avert-AF Scientific Initiative to Develop a Drug Treatment for the Prevention of Atrial Fibrillation
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 24 Apr 2013
Merck Announces Breakthrough Therapy Designation for Lambrolizumab an Investigational Antibody Therapy for Advanced Melanoma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 24 Apr 2013
Teva Establishes Global Specialty Medicines Group
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Apr 2013
Celsion Corporation Provides Business Update
Biopharmaceuticals Devices Drug Delivery Oncology
 HSMN NewsFeed - 23 Apr 2013
VentiRx Pharmaceuticals Appoints James Kyle Bryan, M.D. as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Apr 2013
FDA Approves Second Drug in BD Simplist(TM) Prefilled Injectable Line of Products
Biopharmaceuticals Devices Drug Delivery Generics FDA
 HSMN NewsFeed - 23 Apr 2013
Nuvo Research announces European launch of Pliaglis(R) by Galderma
Biopharmaceuticals Dermatology Product Launch
 HSMN NewsFeed - 23 Apr 2013
Diamyd Medical Changes Name to Mertiva
Biopharmaceuticals
 HSMN NewsFeed - 22 Apr 2013
ARCA biopharma and Medtronic to Collaborate on Atrial Fibrillation Clinical Trial for Gencaro(TM)
Biopharmaceuticals Devices Monitoring Cardiology
 HSMN NewsFeed - 22 Apr 2013
RXi Pharmaceuticals Appoints H. Paul Dorman and Curtis Lockshin, Ph.D. to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Apr 2013
New Anti-Infectives Company, Allecra Therapeutics, Created With €15 Million Series A Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 15 Apr 2013
Ambit Biosciences Appoints David Parkinson, M.D., to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Apr 2013
David A. Dodd Appointed President & Chief Executive Officer of Aeterna Zentaris Inc.
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Apr 2013
Royalty Pharma Announces Firm Offer to Acquire Elan
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 15 Apr 2013
Lantheus Medical Imaging Realigns Executive Leadership Team
Biopharmaceuticals Radiology Personnel
 HSMN NewsFeed - 15 Apr 2013
Covagen Names Elias Papatheodorou Chief Business Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Apr 2013
Pfizer’s Palbociclib (PD-0332991) Receives Food And Drug Administration Breakthrough Therapy Designation For Potential Treatment Of Patients With Breast Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 10 Apr 2013
Novavax Appoints Amy B. Fix Vice President of Regulatory Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Apr 2013
Lilly Debuts Early Oncology Pipeline Data At AACR Annual Meeting
Biopharmaceuticals Oncology
 HSMN NewsFeed - 9 Apr 2013
Zosano Pharma, Inc. Announces Key Strategic Hire
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 9 Apr 2013
Cleave Biosciences Adds New Investor and $10 Million to Series A Financing
Biopharmaceuticals Oncology Venture Capital Personnel
 HSMN NewsFeed - 8 Apr 2013
NovaDel Announces the Signing of a Definitive Agreement to Sell its NovaMist(TM) Technology and Certain Other Assets
Biopharmaceuticals Drug Delivery Acquisitions
 HSMN NewsFeed - 8 Apr 2013
Ibrutinib Receives Third Oncology Breakthrough Therapy Designation from U.S. Food and Drug Administration
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 8 Apr 2013
Teva Names Ichiro Kikushige as CEO of Teva Seiyaku, Japan
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Apr 2013
Actavis and Valeant Announce Actavis as Exclusive Authorized Generic Marketer of Zovirax(R) Ointment; Co-Promotion Agreements on Zovirax(R) Cream and Cordran(R) Tape
Biopharmaceuticals Generics Distribution
 HSMN NewsFeed - 4 Apr 2013
Aerie Pharmaceuticals Names Vicente Anido, Jr. as Chairman of the Board, and David Epstein as Chairman of Aerie’s Scientific Advisory Board
Biopharmaceuticals Ophthalmology Personnel
 HSMN NewsFeed - 3 Apr 2013
Aquinox Pharmaceuticals Completes US $18 million Series C Financing
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 3 Apr 2013
Collegium Pharmaceutical Names Douglas Carlson to Vice President of Business Development
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 2 Apr 2013
BIND Therapeutics Appoints Gregory I. Berk, M.D. as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Apr 2013
Ferro Announces Sale of Its Pharmaceuticals Business
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 29 Mar 2013
FDA Approves New Drug Application (NDA) for Teva’s Quartette(TM) (levonorgestrel/ethinyl estradiol and ethinyl estradiol) Tablets for the Prevention of Pregnancy
Biopharmaceuticals FDA
 HSMN NewsFeed - 27 Mar 2013
BD Enters Pharmaceutical Industry with New Line of Generic Prefilled Injectable Products
Biopharmaceuticals Generics Drug Delivery FDA
 HSMN NewsFeed - 26 Mar 2013
Acceleron Receives Two FDA Orphan Designations for ACE-536
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 26 Mar 2013
ZIOPHARM Terminates Development of Palifosfamide in Metastatic Soft Tissue Sarcoma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 26 Mar 2013
Clinigen Group plc Acquires Oncology Support Therapy Cardioxane(R) from a World-Leading Pharmaceutical Company
Biopharmaceuticals Oncology Acquisitions
 HSMN NewsFeed - 25 Mar 2013
Theraclone Sciences Secures $14 Million in Additional Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 25 Mar 2013
Novira Therapeutics Completes $25 Million Series A Financing
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 25 Mar 2013
XELJANZ(R) (tofacitinib citrate) Approved in Japan for the Treatment of Adults with Rheumatoid Arthritis (RA)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 25 Mar 2013
Revance Therapeutics Announces Appointment of Lauren Silvernail as Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Mar 2013
Arzerra Receives Approval in Japan
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 22 Mar 2013
FDA Approves GE Healthcare's AdreView(TM) (Iobenguane I 123 Injection) for Cardiac Risk Evaluation in Heart Failure Patients
Biopharmaceuticals Cardiology Radiology FDA
 HSMN NewsFeed - 22 Mar 2013
SciClone Appoints Hong Zhao as Chief Executive Officer, China Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Mar 2013
Results of Lymphoseek(R) Phase 3 Clinical Trials in Breast Cancer Published in Annals of Surgical Oncology
Biopharmaceuticals Oncology
 HSMN NewsFeed - 21 Mar 2013
Takeda Launches New Subsidiary in Ecuador
Biopharmaceuticals
 HSMN NewsFeed - 20 Mar 2013
Valeant Pharmaceuticals International, Inc. Agrees to Acquire Obagi Medical Products, Inc. for $19.75 Per Share in Cash
Biopharmaceuticals Dermatology Mergers & Acquisitions
 HSMN NewsFeed - 20 Mar 2013
Adamas Pharmaceuticals Presents New Traumatic Brain Injury Data From Its Nurelin(TM) Program At American Academy Of Neurology Conference
Biopharmaceuticals Neurology
 HSMN NewsFeed - 18 Mar 2013
Labrys Biologics Announces Key Executive Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Mar 2013
Spectrum Pharmaceuticals Appoints Lee F. Allen, M.D., Ph.D., Industry Veteran, as Chief Medical Officer
Biopharmaceuticals Personnel
Older Biopharmaceutical stories   Return to NewsFeed  
FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!